Overview

Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer

Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
A Phase 1, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules given alone or in combination with paclitaxel in patients with Advanced Gastric Cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Minneamrita Therapeutics LLC
Treatments:
14-O-phosphonooxymethyltriptolide disodium salt